References
- Ross R, Glomset J, Harker L. Response to injury and atherogenesis. Am J Pathol. 1977;86:675–84.
- Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–95.
- Farhey Y, Hess EV. Accelerated atherosclerosis and coronary disease in SLE. Lupus. 1997;6:572–7.
- Del Papa N, Gambini D, Meroni PL. Anti-endothelial cell antibodies and autoimmune diseases. Clin Rev Allergy. 1994;12:275–86.
- Praprotnik S, Blank M, Meroni PL, Rozman B, Eldor A, Shoenfeld Y. Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: The pathogenic and diagnostic implications. Arthritis Rheum. 2001;44:1484–94.
- Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, . Universal definition of myocardial infarction. Circulation. 2007;116:2634–53.
- Chenillot O, Henny J, Steinmetz J, Herbeth B, Wagner C, Siest G. High sensitivity C-reactive protein: Biological variations and reference limits. Clin Chem Lab Med. 2000;38: 1003–11.
- Ge X, Uzunel M, Ericzon BG, Sumitran-Holgersson S. Biliary epithelial cell antibodies induce expression of toll-like receptors 2 and 3: A mechanism for post-liver transplantation cholangitis? Liver Transpl. 2005;11:911–21.
- Westphal JR, Boerbooms AM, Schalwijk CJ, Kwast H, De Weijert M, Jacobs C, . Anti-endothelial cell antibodies in sera of patients with autoimmune diseases: Comparison between ELISA and FACS analysis. Clin Exp Immunol. 1994;96:444–9.
- Cines DB, Lyss AP, Reeber M, Bina M, DeHoratius RJ. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J Clin Invest. 1984;73:611–25.
- Meroni P, Ronda N, Raschi E, Borghi MO. Humoral autoimmunity against endothelium: Theory or reality? Trends Immunol. 2005;26:275–81.
- Fischer K, Brzosko M, Walecka A, Ostanek L, Sawicki M. [Antiendothelial cell antibodies as a risk factor of atherosclerosis in systemic lupus erythematosus]. Ann Acad Med Stetin. 2006;52(Suppl 2):95–9.
- Triolo G, Accardo-Palumbo A, Carbone MC, Ferrante A, Casiglia D, Giardina E. IgG anti-endothelial cell antibodies (AECA) in type I diabetes mellitus; induction of adhesion molecule expression in cultured endothelial cells. Clin Exp Immunol. 1998;111:491–6.
- Farsi A, Domeneghetti MP, Brunelli T, Gori AM, Fedi S, Gensini GF, . Activation of the immune system and coronary artery disease: The role of anti-endothelial cell antibodies. Atherosclerosis. 2001;154:429–36.
- George J, Meroni PL, Gilburd B, Raschi E, Harats D, Shoenfeld Y. Anti-endothelial cell antibodies in patients with coronary atherosclerosis. Immunol Lett. 2000;73:23–7.
- Hu CL, Xiang JZ, Hu FF, Huang CX. Adventitial inflammation: A possible pathogenic link to the instability of atherosclerotic plaque. Med Hypotheses. 2007;68:1262–4.
- Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285:2481–5.
- Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol. 1994;95:244–50.
- Rainger GE, Fisher AC, Nash GB. Endothelial-borne platelet-activating factor and interleukin-8 rapidly immobilize rolling neutrophils. Am J Physiol. 1997;272:H114–22.
- Tobon GJ, Alard JE, Youinou P, Jamin C. Are autoantibodies triggering endothelial cell apoptosis really pathogenic? Autoimmun Rev. 2009;8:605–10.
- Domiciano DS, Carvalho JF, Shoenfeld Y. Pathogenic role of anti-endothelial cell antibodies in autoimmune rheumatic diseases. Lupus. 2009;18:1233–8.